Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension

Am J Physiol. 1995 Apr;268(4 Pt 2):H1483-9. doi: 10.1152/ajpheart.1995.268.4.H1483.

Abstract

Ligation of the ductus arteriosus of the fetal sheep produces severe pulmonary hypertension at birth. Standard tissue bath techniques were used to study third- and fourth-generation pulmonary arteries and veins isolated from fetal sheep with pulmonary hypertension created by ligation of the ductus arteriosus 11-12 days before birth as well as from age-matched control sheep. Vessels pretreated with indomethacin and propranolol were submaximally preconstricted with norepinephrine before exposure to A-23187 (10(-8) to 3 x 10(-7) M), sodium nitroprusside (SNP; 10(-9) to 10(-5) M), and nitric oxide (NO) gas (1-973 ppm). Pulmonary veins in both control and ligated animals relaxed similarly and completely to A-23187, SNP, and NO. Control pulmonary arteries relaxed by 16 +/- 2% to A-23187 and relaxed completely to SNP and NO, with concentration-response curves shifted rightward of those observed in pulmonary veins. Pulmonary arteries from ligated animals did not relax at all to A-23187. SNP relaxations in ligated arteries were shifted rightward of control. Ligated arteries relaxed by only 11 +/- 5% to the highest dose of NO. However, control and ligated pulmonary arteries relaxed similarly to 8-bromoguanosine 3',5'-cyclic monophosphate (8-bromo-cGMP; 10(-5) to 10(-3) M) and atrial natriuretic peptide (10(-9) to 10(-7) M). These data are most simply explained by decreased arterial vascular smooth muscle sensitivity to NO at the level of soluble guanylate cyclase.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / pharmacology
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / biosynthesis*
  • Cyclic GMP / pharmacology
  • Ductus Arteriosus
  • Fetus / metabolism*
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / metabolism*
  • Ligation
  • Nitric Oxide / pharmacology
  • Nitroprusside / pharmacology
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / embryology
  • Pulmonary Artery / metabolism*
  • Sheep
  • Vasoconstriction
  • Vasodilator Agents / pharmacology

Substances

  • Vasodilator Agents
  • Nitroprusside
  • 8-bromocyclic GMP
  • Nitric Oxide
  • Atrial Natriuretic Factor
  • Cyclic GMP